Literature DB >> 17117191

[Incidence of breast cancer before and after implementation of mammography screening].

Solveig Hofvind1, Ragnhild Sørum, Tor Haldorsen, Frøydis Langmark.   

Abstract

BACKGROUND: A nationwide governmentally founded breast cancer screening program for women aged 50 - 69 years was gradually implemented in all Norwegian counties between November 1995 and February 2004 (the Norwegian Breast Cancer Screening Program, NBCSP). Such an implementation is expected to give an initial increased incidence followed by a decrease. We here present general and stage-specific incidences of breast cancer by age groups, in the first 9 counties that implemented the NBCSP. MATERIAL AND
METHOD: The incidence of invasive breast cancer is shown for the counties Akershus, Hordaland, Oslo and Rogaland (AHOR), and Agder (east and west), Telemark, Troms and Finnmark (AgTmTF) for the period 1990-2003. AHOR started the NBCSP in 1995/1996, and AgTmTF started in 1999/2000. The incidence is based on recordings in the main database at the Cancer Registry, and is shown in rates per 100,000 women years.
RESULTS: The incidence of breast cancer in women aged 50-69 years increased from 200 to 350 per 100,000 women years at start-up of the NBCSP and subsequently decreased to approximately 250. Before starting the program, the incidence was higher in women aged 70-74 years than in those aged 50 - 69. This changed in the subsequent period. During 1990-2003, the incidence of breast cancer was stable in women aged 20-49 and in those older than 74 years. At start-up of the NBCSP, a higher proportion of breast cancers in Stadium I were diagnosed as compared to the period before, especially among women aged 50-69 years.
INTERPRETATION: Introduction of the NBCSP has changed the incidence of breast cancer in women aged 50-69 and in those aged 70-74 years.

Entities:  

Mesh:

Year:  2006        PMID: 17117191

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  9 in total

Review 1.  Changing concepts: Menopausal hormone therapy and breast cancer.

Authors:  Rowan T Chlebowski; Garnet L Anderson
Journal:  J Natl Cancer Inst       Date:  2012-03-16       Impact factor: 13.506

Review 2.  Menopausal hormone therapy and breast cancer mortality: clinical implications.

Authors:  Rowan T Chlebowski; Garnet L Anderson
Journal:  Ther Adv Drug Saf       Date:  2015-04

3.  Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.

Authors:  Rowan T Chlebowski; JoAnn E Manson; Garnet L Anderson; Jane A Cauley; Aaron K Aragaki; Marcia L Stefanick; Dorothy S Lane; Karen C Johnson; Jean Wactawski-Wende; Chu Chen; Lihong Qi; Shagufta Yasmeen; Polly A Newcomb; Ross L Prentice
Journal:  J Natl Cancer Inst       Date:  2013-03-29       Impact factor: 13.506

Review 4.  Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.

Authors:  Rowan T Chlebowski; Garnet L Anderson
Journal:  Steroids       Date:  2014-06-06       Impact factor: 2.668

Review 5.  Advanced breast cancer incidence following population-based mammographic screening.

Authors:  P Autier; M Boniol; R Middleton; J F Doré; C Héry; T Zheng; A Gavin
Journal:  Ann Oncol       Date:  2011-01-20       Impact factor: 32.976

6.  Evaluating different breast tumor progression models using screening data.

Authors:  Åsbjørn Schumacher Westvik; Harald Weedon-Fekjær; Jan Mæhlen; Knut Liestøl
Journal:  BMC Cancer       Date:  2018-02-20       Impact factor: 4.430

7.  Comparison of the ductal carcinoma in situ between White Americans and Chinese Americans.

Authors:  Xin-Wen Kuang; Zhi-Hong Sun; Jun-Long Song; Zhanyong Zhu; Chuang Chen
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

Review 8.  Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.

Authors:  Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  BMJ       Date:  2009-07-09

9.  The associations of sitting time and physical activity on total and site-specific cancer incidence: Results from the HUNT study, Norway.

Authors:  Vegar Rangul; Erik R Sund; Paul Jarle Mork; Oluf Dimitri Røe; Adrian Bauman
Journal:  PLoS One       Date:  2018-10-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.